Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

siRNA-mediated gene silencing of Vascular Endothelial Growth factor (VEGF) for the treatment of neovascular pathologies of the eye.

Ilana Silverstein; Adrienne Conza; Delaney Giguere; Julia Alterman; Dimas Echeverria; Katherine Gross; Shun-Yun cheng; Anastasia Khvorova; Claudio Punzo

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):236.

ARVO Annual Meeting Abstract June 2024

Genetic and pharmacological reduction of S6K1 alleviates pathologies in the mouse model of age-related macular degeneration (AMD)

Shun-Yun cheng; Dimas Echeverria; Delaney Giguere; Julia Alterman; Martin-Paul Gameli Agbaga; Johanna M Seddon; Anastasia Khvorova; Claudio Punzo

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6519.

ARVO Annual Meeting Abstract June 2023

Modified siRNA exhibit robust, safe and long-term gene silencing in the retina

Shun-Yun cheng; Jillian Caiazzi; Delaney Giguere; Julia F. Alterman; Dimas Echeverria Moreno; Annabelle Biscans; Matthew Hassler; Anastasia Khvorova; Claudio Punzo

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2603.

ARVO Annual Meeting Abstract March 2012

Novel Anti-CTGF RNAi Therapy for Treatment of Proliferative Vitreoretinopathy (PVR) and other Ocular Disorders

Michael J. Byrne; Glenna Ford; James Cardia; Lakshmipathi Pandarinathan; Karen Bulock; Lyn Libertine; Kevin Fettes; Pamela Pavco; Anastasia Khvorova

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):897.

ARVO Annual Meeting Abstract April 2011

Self-delivering RNAi Compounds (sd-rxRNATm) Demonstrate Robust Efficacy In Vivo In The Mouse Eye

Pamela A. Pavco; Michael Byrne; Radouil Tzekov; Yi Wang; Amanda Rodgers; James Cardia; Karen Bulock; Lyn Libertine; Anastasia Khvorova; Shalesh Kaushal

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1426.

Advertisement